Obesity and the hypertensive disorders of pregnancy obesity and hypertensive disorders

Hypertension in Pregnancy

Volumn 28, Issue 4, 2009, Pages 473-493

  Callaway, Leonie Kaye ^a   O'Callaghan, Michael ^b   David McIntyre, H ^c  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b Mater Hospital   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Gestational hypertension; Hypertension; Obesity.; Preeclampsia; Pregnancy

Indexed keywords

ADIPONECTIN; INTERLEUKIN 1; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

DISEASE ASSOCIATION; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; FEMALE; GENETIC PREDISPOSITION; HUMAN; IMMUNOPATHOLOGY; INSULIN RESISTANCE; MATERNAL HYPERTENSION; OBESITY; PHYSICAL ACTIVITY; REVIEW; THROMBOSIS;

ADIPOCYTES; ENDOTHELIAL CELLS; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INSULIN RESISTANCE; OBESITY; PREGNANCY;

EID: 70350333278     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641950802629626     Document Type: Review

References (79)

1. O'Brien TE, Ray JG, Chan WS. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 2003; 14:368-374.
2. Ros HS, Cnattingius S, Lipworth L. Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study. Am J Epidemiol 1998; 147:1062-1070.
3. Villar J, Carroli G, Wojdyla D, et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol 2006; 194:921-931.
4. Conde-Agudelo A, Belizan JM. Risk factors for preeclampsia in a large cohort of Latin American and Caribbean women. BJOG 2000; 107:75-83.
5. Sebire NJ, Jolly M, Harris JP, et al. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord 2001; 25:1175-1182.
6. Callaway LK, Prins JB, Chang AM, et al. The prevalence and impact of overweight and obesity in an Australian obstetric population. Med J Aust 2006; 184:56-59.
7. Baeten JM, Bukusi EA, Lambe M. Pregnancy complications and outcomes among overweight and obese nulliparous women. Am J Public Health 2001; 91:436-440.
8. Weiss JL, Malone FD, Emig D, et al. Obesity, obstetric complications and cesarean delivery rate-a population-based screening study. Am J Obstet Gynecol 2004; 190:1091-1097.
9. Thadhani R, Stampfer MJ, Hunter DJ, et al. High body mass index and hypercholesterolemia: risk of hypertensive disorders of pregnancy. Obstet Gynecol 1999; 94:543-550.
10. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988;158:892-898.
11. Strevens H, Wide-Swensson D, Hansen A, et al. Glomerular endotheliosis in normal pregnancy and preeclampsia. Bjog 2003;110:831-836.
12. Buchbinder A, Sibai BM, Caritis S, et al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol 2002;186:66-71.
13. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i-xii, 1-253.
14. Haslam DW, James WP. Obesity. Lancet 2005;366:1197-1209.
15. Prins JB. Adipose tissue as an endocrine organ. Best Pract Res Clin Endocrinol Metab 2002;16:639-651.
16. O'Rahilly S, Farooqi IS. Genetics of obesity. Philosophical transactions of the Royal Society of London 2006;361:1095-1105.
17. Bouchard C, Tremblay A, Despres JP, et al. Overfeeding in identical twins: 5-year postoverfeeding results. Metabolism 1996;45:1042-1050.
18. Coll AP, Farooqi IS, O'Rahilly S. The hormonal control of food intake. Cell 2007;129:251-262.
19. Plagemann A. Perinatal programming and functional teratogenesis: impact on body weight regulation and obesity. Physiology Behavior 2005;86:661-668.
20. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444:840-846.
21. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444:860-867.
22. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6:772-783.
23. Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006; 444:847-853.
24. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444:875-880.
25. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365:1415-1428.
26. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol 2006; 26:968-976.
27. Ryo M, Nakamura T, Kihara S, et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004; 68:975-981.
28. Diet, nutrition and the prevention of chronic diseases. World Health Organ Tech Rep Ser 2003; 916:i-viii, 1-149, backcover.
29. Mott DM, Lillioja S, Bogardus C. Overnutrition induced decrease in insulin action for glucose storage: in vivo and in vitro in man. Metabolism 1986; 35:160-165.
30. Vessby B, Unsitupa M, Hermansen K, et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia 2001; 44:312-319.
31. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336:1117-1124.
32. Raben A, Vasilaras TH, Moller AC, et al. Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects. Am J Clin Nutr 2002; 76:721-729.
33. Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol 2006; 48:677-685. (Pubitemid 44175717)
34. Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006; 195:40-49.
35. Sibai B, Dekker G, Kupferminc M. Preeclampsia. Lancet 2005;365:785-799.
36. Solomon CG, Seely EW. Hypertension in pregnancy. Endocrinol Metab Clin North Am 2006; 35:157-171, vii.
37. Hiby SE, Walker JJ, O'Shaughnessy KM, et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004; 200:957-965.
38. Wimalasundera RC, Larbalestier N, Smith JH, et al. Preeclampsia, antiretroviral therapy, and immune reconstitution. Lancet 2002; 360:1152-1154.
39. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111:649-658.
40. Roberts JM, Taylor RN, Musci TJ, et al. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161:1200-1204.
41. Cincotta RB, Brennecke SP. Family history of preeclampsia as a predictor for preeclampsia in primigravidas. Int J Gynaecol Obstet 1998; 60:23-27.
42. Duckitt K, Harrington D. Risk factors for preeclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005; 330:565.
43. Arngrimsson R, Bjornsson S, Geirsson RT, et al. Genetic and familial predisposition to eclampsia and preeclampsia in a defined population. Br J Obstet Gynaecol 1990; 97:762-769.
44. Esplin MS, Fausett MB, Fraser A, et al. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med 2001; 344:867-872.
45. Disentangling fetal and maternal susceptibility for preeclampsia: a British multicenter candidate-gene study. Am J Hum Genet 2005; 77:127-131.
46. Isganaitis E, Lustig RH. Fast food, central nervous system insulin resistance, and obesity. Arterioscler Thromb Vasc Biol 2005; 25:2451-2462.
47. Morris CD, Jacobson SL, Anand R, et al. Nutrient intake and hypertensive disorders of pregnancy: Evidence from a large prospective cohort. Am J Obstet Gynecol 2001; 184:643-651.
48. Clausen T, Slott M, Solvoll K, et al. High intake of energy, sucrose, and polyunsaturated fatty acids is associated with increased risk of preeclampsia. Am J Obstet Gynecol 2001; 185:451-458.
49. Williams SB, Goldfine AB, Timimi FK, et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 1998; 97:1695-1701.
50. Lustig RH. Childhood obesity: behavioral aberration or biochemical drive? Reinterpreting the first law of thermodynamics. Nat Clin Pract Endocrinol Metab 2006; 2:447-458.
51. Sorensen TK, Williams MA, Lee IM, et al. Recreational physical activity during pregnancy and risk of preeclampsia. Hypertension 2003; 41:1273-1280.
52. Rudra CB, Williams MA, Lee IM, et al. Perceived exertion during prepregnancy physical activity and preeclampsia risk. Med Sci Sports Exerc 2005; 37:1836-1841.
53. Saftlas AF, Logsden-Sackett N, Wang W, et al. Work, leisure-time physical activity, and risk of preeclampsia and gestational hypertension. Am J Epidemiol 2004; 160:758-765.
54. Ramsay JE, Ferrell WR, Crawford L, et al. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 2002; 87:4231-4237.
55. Hendler I, Blackwell SC, Mehta SH, et al. The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia. Am J Obstet Gynecol 2005; 193:979-983.
56. Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358:1991-2002.
57. Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 2004; 103:219-224.
58. Dixon JB, Dixon ME, O'Brien PE. Birth outcomes in obese women after laparoscopic adjustable gastric banding. Obstet Gynecol 2005; 106:965-972.
59. Cedergren M. Effects of gestational weight gain and body mass index on obstetric outcome in Sweden. Int J Gynaecol Obstet 2006; 93:269-274.
60. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444:881-887.
61. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23:469-480.
62. Sattar N, Clark P, Holmes A, et al. Antenatal waist circumference and hypertension risk. Obstet Gynecol 2001; 97:268-271.
63. Parretti E, Lapolla A, Dalfra M, et al. Preeclampsia in lean normotensive normotolerant pregnant women can be predicted by simple insulin sensitivity indexes. Hypertension 2006; 47:449-453.
64. Wolf M, Sandler L, Jimenez-Kimble R, et al. Insulin resistance but not inflammation is associated with gestational hypertension. Hypertension 2002; 40:886-891.
65. Solomon CG, Carroll JS, Okamura K, et al. Higher cholesterol and insulin levels in pregnancy are associated with increased risk for pregnancy-induced hypertension. Am J Hypertens 1999; 12:276-282.
66. Wolf M, Sandler L, Munoz K, et al. First trimester insulin resistance and subsequent preeclampsia: a prospective study. J Clin Endocrinol Metab 2002; 87:1563-1568.
67. Lorentzen B, Drevon CA, Endresen MJ, et al. Fatty acid pattern of esterified and free fatty acids in sera of women with normal and preeclamptic pregnancy. Br J Obstet Gynaecol 1995; 102:530-537.
68. Maasilta P, Bachour A, Teramo K, et al. Sleep-related disordered breathing during pregnancy in obese women. Chest 2001; 120:1448-1454.
69. Ness RB, Markovic N, Harger G, et al. Barrier methods, length of preconception intercourse, and preeclampsia. Hypertens Pregnancy 2004; 23:227-235.
70. Skjaerven R, Wilcox AJ, Lie RT. The interval between pregnancies and the risk of preeclampsia. N Engl J Med 2002; 346:33-38.
71. Grodstein F, Goldman MB, Cramer DW. Body mass index and ovulatory infertility. Epidemiology 1994; 5:247-250.
72. Rich-Edwards JW, Spiegelman D, Garland M, et al. Physical activity, body mass index, and ovulatory disorder infertility. Epidemiology 2002; 13:184-190.
73. Gratacos E, Torres PJ, Cararach V, et al. Does the use of contraception reduce the risk of pregnancy-induced hypertension? Hum Reprod 1996; 11:2138-2141.
74. Einarsson JI, Sangi-Haghpeykar H, Gardner MO. Sperm exposure and development of preeclampsia. Am J Obstet Gynecol 2003; 188:1241-1243.
75. Robillard PY, Hulsey TC, Perianin J, et al. Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception. Lancet 1994; 344:973-975.
76. Morcos RN, Bourguet CC, Gill PP, et al. Pregnancy-induced hypertension and duration of sexual cohabitation. J Reprod Med 2000; 45:207-212.
77. Klonoff-Cohen HS, Savitz DA, Cefalo RC, et al. An epidemiologic study of contraception and preeclampsia. Jama 1989; 262:3143-3147.
78. Dempsey JC, Williams MA, Luthy DA, et al. Weight at birth and subsequent risk of preeclampsia as an adult. Am J Obstet Gynecol 2003; 189:494-500.
79. Innes KE, Marshall JA, Byers TE, et al. A woman's own birth weight and gestational age predict her later risk of developing preeclampsia, a precursor of chronic disease. Epidemiology 1999; 10:153-160.